AbbVie
ABBV
ABBV
3,371 hedge funds and large institutions have $228B invested in AbbVie in 2024 Q1 according to their latest regulatory filings, with 220 funds opening new positions, 1,330 increasing their positions, 1,489 reducing their positions, and 115 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2% more funds holding
Funds holding: 3,314 → 3,371 (+57)
1.24% less ownership
Funds ownership: 72.24% → 70.99% (-1.2%)
11% less repeat investments, than reductions
Existing positions increased: 1,330 | Existing positions reduced: 1,489
Holders
3,371
Holding in Top 10
224
Calls
$3.29B
Puts
$2.55B
Top Buyers
| 1 | +$1.72B | |
| 2 | +$616M | |
| 3 | +$538M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$536M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$397M |
Top Sellers
| 1 | -$5.68B | |
| 2 | -$423M | |
| 3 | -$391M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$315M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$299M |